Data from several large randomized controlled trials have shown that elevated albumin:creatinine ratio (ACR) is associated with increased risk of new‐onset heart failure.11 Furthermore, RAAS modulation with either an angiotensin‐converting enzyme (ACE) inhibitor or angiotensin receptor blocker decreases the risk of heart failure hospitalization.12, 13. The gene discussed is ACE; the disease is heart failure.